BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6227)

  • 1. Decrease in the activity of the drug-metabolizing enzymes of rat liver following the administration of tilorone hydrochloride.
    Leeson GA; Biedenbach SA; Chan KY; Gibson JP; Wright GJ
    Drug Metab Dispos; 1976; 4(3):232-8. PubMed ID: 6227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of the hepatic cytochrome P-450 mono-oxygenase system by administered tilorone (2,7-bis(2-(diethylamino)ethoxy)fluoren-9-one dihydrochloride).
    Renton KW; Mannering GJ
    Drug Metab Dispos; 1976; 4(3):223-31. PubMed ID: 6226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of thiamine on the activity of liver endoplasmic reticulum enzymes metabolizing drugs].
    Sushko LI; Lukienko PI
    Farmakol Toksikol; 1979; 42(1):56-9. PubMed ID: 421893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of muroctasin on the activities of drug metabolizing enzymes in liver microsomes of rats.
    Kamataki T; Komori M; Iwasaki M; Ohi H; Kitada M; Miura T; Ono K
    Arzneimittelforschung; 1988 Jul; 38(7A):1019-22. PubMed ID: 3263867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of ethylenethiorea on microsomal liver enzymes in the rat].
    Plass R; Lewerenz HJ
    Arch Exp Veterinarmed; 1978; 32(4):585-91. PubMed ID: 727871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tetrachlorophthalic anhydride on hepatic microsomal metabolism in rats and mice.
    Ridley WP; Warren J; Nair RS
    J Toxicol Environ Health; 1988; 24(2):217-27. PubMed ID: 3385798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of neonatal androgen in the development of hepatic microsomal drug-metabolizing enzymes.
    Chung LW; Raymond G; Fox S
    J Pharmacol Exp Ther; 1975 May; 193(2):621-30. PubMed ID: 1142108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of diispropyl 1, 3-dithiol-2-ylidene malonate (NKK-105) on the drug-metabolizing enzymes and fine structure of rat liver (author's transl)].
    Nakayama S
    Nihon Yakurigaku Zasshi; 1979 Sep; 75(6):571-84. PubMed ID: 120299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nifedipine on the enzyme-inducing activity of phenobarbital and beta-naphthoflavone.
    Koleva M; Staneva-Stoytcheva D
    Acta Physiol Pharmacol Bulg; 1991; 17(2-3):122-8. PubMed ID: 1819909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on correlation between liver drug metabolizing enzyme activities and microsomal membrane fluidity in phenobarbital treated rats].
    Fu LS; Peng RX
    Yao Xue Xue Bao; 1991; 26(8):567-71. PubMed ID: 1805518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic effect of methadone on hepatic drug metabolism.
    Komthong S; Yoovathaworn K; Thithapandha A
    Proc Soc Exp Biol Med; 1987 Jan; 184(1):40-6. PubMed ID: 3797427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of praseodymium chloride on liver microsomal enzymes of rats.
    Oga S; Galvão JF; Yasaka WJ; Araujo Filho AP
    Life Sci; 1986 Jun; 38(22):2029-36. PubMed ID: 3086648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of hepatic enzymes by methaqualone and effect on warfarin-induced hypoprothrombinemia.
    Mathur PP; Smyth RD; Herczeg T; Reavey-Cantwell NH
    J Pharmacol Exp Ther; 1976 Jan; 196(1):204-12. PubMed ID: 1246011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of "drugs for liver disease" on hepatotoxic action of carbon tetrachloride. II. Effect of protoporphyrin and phosphorylcholine on microsomal drug-metabolizing enzyme activities and the components in injuried liver.
    Ogiso T; Kobayashi T; Kuhara K; Kato Y
    Jpn J Pharmacol; 1975 Aug; 25(4):411-21. PubMed ID: 813044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
    Atal CK; Dubey RK; Singh J
    J Pharmacol Exp Ther; 1985 Jan; 232(1):258-62. PubMed ID: 3917507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dantrolene inhibition of the hepatic mixed function oxidase system.
    Francis KT; Hamrick ME
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):69-80. PubMed ID: 441518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experimental studies of the duration of hexobarbital sleep and of the level of cytochrom P-450 and B5 in the microsomal fraction of rat liver after propoxur treatment].
    Nenov P; Ribarova F
    Eksp Med Morfol; 1978; 17(3):118-21. PubMed ID: 699864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the inductive effects of phenobarbital and 3-methylcholanthrene on ascorbic acid synthesis and hepatic cytochrome P-450-linked monooxygenase systems by the interferon inducers, poly rI.rC and tilorone.
    Renton KW; Keyler DE; Mannering GJ
    Biochem Biophys Res Commun; 1979 Jun; 88(3):1017-23. PubMed ID: 465068
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of certain vitamin deficiencies on hepatic drug metabolism.
    Zannoni VG; Sato PH
    Fed Proc; 1976 Nov; 35(13):2464-9. PubMed ID: 976490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of platinum and palladium salts on parameters of drug metabolism in rat liver.
    Holbrook DJ; Washington ME; Leake HB; Brubaker PE
    J Toxicol Environ Health; 1976 Jul; 1(6):1067-79. PubMed ID: 966317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.